Nolan R. Shaw

Counsel

Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.

Nolan Shaw is a counsel in O’Melveny’s Hong Kong office. His practice focuses on cross-border US mergers and acquisitions, venture capital investments, foreign direct investment into China and general corporate matters involving a variety of industry sectors, including electric car vehicles, life sciences, cloud computing, film and entertainment, retail, manufacturing, and others.

Nolan previously served as seconded legal counsel to the Real Estate strategy of Pacific Alliance Group (PAG) for six months in late 2017 and early 2018, where he covered acquisitions by PAG in mainland China, Hong Kong, South Korea, and New Zealand, including PAG’s acquisition of a majority stake in China Merchants buildings located in Beijing and Shanghai.

Languages

  • Mandarin Chinese

Admissions

Bar Admissions

  • California
  • Hong Kong (Registered Foreign Lawyer)

Education

  • University of California, Hastings College of the Law, J.D.: cum laude
  • California State Polytechnic University, Pomona, B.S.; M.A.

Mergers and Acquisitions / Private Equity

  • A buyer consortium led by Yunfeng Capital, TF Capital, GIC and management in connection with the acquisition of Cellular Biomedicine Group in a “going private” transaction valued at approximately US$380 million
  • Lucid Motors in connection with its US$1+ billion investment by the Public Investment Fund of the Kingdom of Saudi Arabia
  • SEEK Limited in connection with a number of investments, acquisitions and dispositions involving companies in North and South America, including Go1 and Revelo
  • eHi Car Services Limited in connection with its acquisition and de-listing by a consortium comprised of members of company management, The Crawford Group, MBK Partners, Ctrip Investment Holdings and Ocean Link
  • Starr Companies in connection with its Series C investment in Gushengtang, a Chinese traditional medicine health services company
  • Guangzhou Auto in connection with its Series B investment in and strategic arrangement with Uber China
  • Home improvement retailer Kingfisher plc in connection with its sale of a majority stake in B&Q China to Chinese acquirer Wu-mart
  • China e-commerce platform business operator Yihaodian in connection with its establishment of a foreign-invested telecoms enterprise in the Shanghai Free Trade Zone